Skip to content
Screener

Viking Therapeutics VKTX Other Non-Current Assets

Other Non-Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$7.48B+20.2%
Amgen logo
AmgenAMGN
$12.98B+17.7%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$7.34M+37.6%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$21.11M
VAN
Vivani MedicalVANI
$1.34M0.0%
Altimmune logo
AltimmuneALT
$746K-53.9%

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$3.88B+8.4%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DepositsAssetsNoncurrent.

The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 9:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-193315
Line itemMarch 31,2026December 31,2025
Prepaid expenses and other current assets1,2241,806
Total current assets608,209715,598
Right-of-use assets85
Deposits3346
Total assets$608,242$715,729
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$67,183$53,251

Item 1. Financial Statements

FAQ

What is Viking Therapeutics's other non-current assets?
Viking Therapeutics (VKTX) reported other non-current assets of $33K in Q1 2026.
How has Viking Therapeutics's other non-current assets changed year-over-year?
Viking Therapeutics's other non-current assets decreased by 28.3% year-over-year, from $46K to $33K.
What is the long-term trend for Viking Therapeutics's other non-current assets?
Over 5 years (2020 to 2025), Viking Therapeutics's other non-current assets has grown at a 9.7% compound annual growth rate (CAGR), from $29K to $46K.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Viking Therapeutics's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude